Applied Clinical Trials-02-01-2023

Considerations to help tailor new tools as part of a custom clinical trial strategy.

Simultaneous and niche skills sought amid evolution in clinical data management.

Assessing industry’s use and integration of clinical data science across business.

Despite high potential of DHTs, regulatory picture remains unclear.

Probe targets agency’s role in advising on drug testing and submissions.

Highlights from the annual SCOPE conference held in Orlando, FL.

Click the title above for a link to open the Applied Clinical Trials January/February 2023 issue in an interactive PDF format.

DCTs and RWD among topics for industry to focus on moving into 2023.

The issues engulfing compliance with the Clinical Trials Regulation signal that even the best intentions with these types of laws may not be enough to avert unintended consequences.

How evidence generated by the latest IgniteData ‘real-setting’ pilot study supports the case for clinical trial transformation.

Sam Whitaker, co-founder and co-CEO of Mural Health discusses his time in the industry and patient needs in the current clinical trials market.